• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38787.15
  • 1.31 %
  • 503.37
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Biomerica, Inc. (BMRA) Stock Price, News & Analysis

Biomerica, Inc. (BMRA) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.33

$0.01

(2.01%)

Day's range
$0.31
Day's range
$0.34
50-day range
$0.2799
Day's range
$0.4354
  • Country: US
  • ISIN: US09061H3075
52 wk range
$0.24
Day's range
$2.13


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -8.88
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (BMRA)
  • Company Biomerica, Inc.
  • Price $0.33
  • Changes Percentage (2.01%)
  • Change $0.01
  • Day Low $0.31
  • Day High $0.34
  • Year High $2.13

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 01/14/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.37
  • Trailing P/E Ratio -1.46
  • Forward P/E Ratio -1.46
  • P/E Growth -1.46
  • Net Income $-5,978,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Biomerica, Inc. Frequently Asked Questions

  • What were the earnings of BMRA in the last quarter?

    In the last quarter Biomerica, Inc. earnings were on Thursday, April, 14th. The Biomerica, Inc. maker reported -$0.01 EPS for the quarter, beating analysts' consensus estimates of -$0.10 by $0.09.

  • What is the Biomerica, Inc. stock price today?

    Today's price of Biomerica, Inc. is $0.33 — it has increased by +2.01% in the past 24 hours. Watch Biomerica, Inc. stock price performance more closely on the chart.

  • Does Biomerica, Inc. release reports?

    Yes, you can track Biomerica, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Biomerica, Inc. stock forecast?

    Watch the Biomerica, Inc. chart and read a more detailed Biomerica, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Biomerica, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Biomerica, Inc. stock ticker.

  • How to buy Biomerica, Inc. stocks?

    Like other stocks, BMRA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Biomerica, Inc.'s EBITDA?

    Biomerica, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Biomerica, Inc.’s financial statements.

  • What is the Biomerica, Inc.'s net income ratio for the financial year 2024?

    The net income ratio for the financial year 2024 is -1.1039704524, which equates to approximately -110.40%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Biomerica, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Biomerica, Inc.'s financials relevant news, and technical analysis. Biomerica, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Biomerica, Inc. stock currently indicates a “sell” signal. For more insights, review Biomerica, Inc.’s technical analysis.

  • A revenue figure for Biomerica, Inc. for its last quarter?

    Biomerica, Inc. published it's last quarterly revenues at $1.81 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.